PROM1 and neoplasm: The CD8/CD133 and CD8/TB indices, as well as the CD133-adjacent CD8+ T and TB-adjacent CD8+ T cells, encompass a tumor and host-related features, and therefore represent a more advantageous ‘multi-marker’ approach to prognosis, thus better reflecting tumor dynamics in the TME.